Skip to main content
OpenTrials
Completed

NCT Number: NCT07817836

Urban Exposome and Biological Age

The goal of this observational study is to evaluate the impact of the urban exposome, including air pollution and lifestyle-related stressors, on biological aging, inflammatory pathways, oxidative stress, and DNA methylation patterns in healthy workers exposed to urban air pollution in the city of Pavia, Italy.

The study population included 151 adult workers, divided into two groups: outdoor workers (including police officers, taxi drivers, and dustmen) and an indoor control group composed of office workers from the University of Pavia and ICS Maugeri hospital with minimal outdoor exposure.

The main questions it aims to answer are:

* Does chronic exposure to urban air pollutants such as NO2, SO2, O3, benzene, volatile organic compounds, and PM2.5 influence inflammatory cytokines, oxidative stress markers, and biological aging? * Is exposure to urban pollution associated with changes in DNA methylation patterns and epigenetic age acceleration? * How do lifestyle factors, nutritional status, sleep quality, physical activity, smoking habits, and perceived quality of life interact with the urban exposome and biological outcomes?

Researchers will compare outdoor workers with indoor workers to evaluate differences in environmental exposure, inflammatory biomarkers, oxidative stress, DNA methylation profiles, and estimated biological age.

Participants will:

* Undergo clinical assessments, with interviews regarding occupational history. * Undergo anthropometric and nutritional evaluations, including body composition analysis and blood chemistry tests; answer questionnaires about physical activity, smoking habits, sleep quality, and perceived quality of life; undergo interviews about dietary habits. * Wear passive personal air samplers for approximately 5 working days to measure exposure to urban air pollutants. * Provide blood samples for analysis of inflammatory cytokines, oxidative stress markers, thyroid-related biomarkers, and epigenetic modifications. * Undergo DNA methylation analyses using epigenetic techniques to estimate biological age and evaluate associations between pollutant exposure and epigenetic changes. * Receive feedback regarding their environmental exposure and general health and nutritional status.

This interdisciplinary observational study adopts an exposome-based approach integrating environmental monitoring, occupational medicine, nutrition, and epigenetics to better understand the relationship between urban environmental exposure and human health.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Occupational medicine Unit

Pavia, PV, 27100, Italy

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults aged 18 years or older;
  • Male or female participants;
  • Ability and willingness to provide written informed consent;
  • Employment in occupations performed predominantly outdoors in an urban environment with exposure to atmospheric pollution, i.e. employment as urban police officers, police personnel, public transport workers, taxi drivers, newsstand workers, or other outdoor urban workers in the city of Pavia;
  • Employment in predominantly indoor office-based occupations with minimal occupational exposure to outdoor urban air pollution (control group), i.e. workers undergoing occupational health surveillance at ICS Maugeri or affiliated institutions.

Exclusion criteria

  • Current diagnosis of active oncological disease;
  • Current treatment with immunosuppressive therapy;
  • Inability or unwillingness to provide informed consent;
  • Medical conditions preventing participation in blood sampling or study assessments;
  • Pregnancy or breastfeeding (if applicable and according to Ethics Committee recommendations).

Treatment and study plan

Primary outcomes

  1. DNA Methylation Profile Associated With Urban Air Pollution Exposure

    Time frame: Baseline

    DNA methylation patterns are evaluated in peripheral blood samples from participants exposed to different levels of urban air pollution. Genomic DNA is extracted and analyzed using bisulfite sequencing, quantitative polymerase chain reaction (qPCR), and pyrosequencing techniques to quantify DNA methylation in specific genomic regions. Methylation measures are evaluated in relation to participants' measured exposure to urban air pollutants.

Secondary outcomes

  1. Biological Age Estimated using an Epigenetic Clock Analysis in Workers Exposed to Urban Air Pollution

    Time frame: Baseline

    Biological age is estimated using an epigenetic clock algorithm based on DNA methylation patterns measured in peripheral blood samples. Biological age estimates are compared between workers highly exposed to urban air pollution during outdoor occupational activities and workers with minimal occupational exposure to outdoor urban air pollution.

Other outcomes

  1. Blood Glucose Concentration

    Time frame: Baseline

    Blood glucose concentration measured from the peripheral blood sample to characterize glucose metabolism. Unit: mg/dL

  2. Serum Insulin Concentration

    Time frame: Baseline

    Serum insulin concentration measured to characterize glucose and insulin metabolism.

    Unit: mIU/L

  3. Homeostatic Model Assessment of Insulin Resistance (HOMA-IR)

    Time frame: Baseline

    HOMA-IR is calculated from fasting glucose and insulin concentrations as an estimate of insulin resistance.

  4. Mean Corpuscular Volume

    Time frame: Baseline

    Mean corpuscular volume (MCV) measured as part of the complete blood count. Unit: fL

  5. Hemoglobin Concentration

    Time frame: Baseline

    Hemoglobin concentration measured in peripheral blood as part of the complete blood count.

    Unit: g/L

  6. Leukocyte Count

    Time frame: Baseline

    Leukocyte count measured in peripheral blood as part of the complete blood count. Unit: 10^9/L

  7. Leukocyte Telomere Length in Relation to Urban Air Pollution Exposure

    Time frame: Baseline

    Telomere length is measured in peripheral blood leukocytes as a biomarker of biological aging and cellular senescence. Analyses evaluate associations between telomere length and exposure to urban air pollutants.

  8. Creatinine Concentration

    Time frame: Baseline

    Serum Creatinine Concentration. Unit: mg/dL

  9. Estimated Glomerular Filtration Rate

    Time frame: Baseline

    Estimated glomerular filtration rate (eGFR) used to characterize renal function.

    Unit: mL/min/1.73 m²

  10. Serum Folate Concentration

    Time frame: Baseline

    Unit: µg/L

  11. Serum Vitamin B12 Concentration

    Time frame: Baseline

    Unit: ng/L

  12. Plasma Homocysteine Concentration

    Time frame: Baseline

    Unit: µmol/L

  13. FIB-4 Index

    Time frame: Baseline

    FIB-4 is a non-invasive index of liver fibrosis calculated from age, AST, ALT, and platelet count.

  14. Aspartate Aminotransferase (AST) Concentration

    Time frame: Baseline

    Unit: U/L

  15. Alanine Aminotransferase (ALT) Concentration

    Time frame: Baseline

    Unit: U/L

  16. Gamma-Glutamyl Transferase Concentration

    Time frame: Baseline

    Unit: U/L

  17. Total Cholesterol Concentration

    Time frame: Baseline

    Unit: mg/dL

  18. HDL Cholesterol Concentration

    Time frame: Baseline

    Unit: mg/dL

  19. LDL Cholesterol Concentration

    Time frame: Baseline

    Unit: mg/dL

  20. Triglyceride Concentration

    Time frame: Baseline

    Unit: mg/dL

  21. Serum 25-Hydroxyvitamin D Concentration

    Time frame: Baseline

    Unit: µg/L

  22. Serum Thyroid-Stimulating Hormone (TSH) Concentration

    Time frame: Baseline

    Unit: mUI/L

  23. Serum Free Triiodothyronine (FT3) Concentration

    Time frame: Baseline

    Unit: ng/L

  24. Serum Free Thyroxine (FT4) Concentration

    Time frame: Baseline

    Unit: ng/dL

  25. Anti-Thyroglobulin Antibody Concentration

    Time frame: Baseline

    Unit: KUI/L

  26. Anti-Thyroid Peroxidase Antibody Concentration

    Time frame: Baseline

    Unit: KUI/L

  27. Body Mass Index (BMI)

    Time frame: Baseline

    Body mass index (BMI) is calculated as body weight in kilograms divided by height in meters squared (kg/m²) and is used to assess overall body size.

  28. Waist-to-Hip Ratio (WHR)

    Time frame: Baseline

    Waist-to-hip ratio (WHR) is calculated from waist and hip circumference measurements as an indicator of body fat distribution.

  29. Waist-to-height ratio (WHtR)

    Time frame: Baseline

    Waist-to-height ratio (WHtR) is calculated from waist circumference and height measurements as an indicator of central adiposity.

  30. Bioelectrical Impedance Phase Angle

    Time frame: Baseline

    Phase angle is measured by bioelectrical impedance analysis using the BIA 101 device (BIVA® PRO, Akern) as an indicator of cellular integrity and body composition status. Phase angle is reported in degrees.

  31. Handgrip Strength

    Time frame: Baseline

    Handgrip strength is measured using a digital handgrip dynamometer (GripwiseTech). 3 test on non dominant hand are repeated and the mean value is used as an indicator of handgrip strenght.

  32. Liver Stiffness Measured by Transient Elastography

    Time frame: Baseline

    Liver stiffness is measured by transient elastography (FibroScan® Compact 530, Echosens SA) and reported in kilopascals (kPa).

  33. Controlled Attenuation Parameter (CAP)

    Time frame: Baaseline

    The Controlled Attenuation Parameter (CAP) is measured by transient elastography (FibroScan® Compact 530, Echosens SA) to estimate hepatic steatosis.

  34. Mediterranean Diet Adherence score (Medi-Lite)

    Time frame: Baseline

    Adherence to the Mediterranean diet is assessed using the validated MEDI-LITE questionnaire (doi: 10.1080/09637486.2017.1287884.).

    The questionnaire evaluates the usual consumption of nine dietary components: fruit, vegetables, legumes, cereals, fish and fish products, meat and processed meat, milk and dairy products, alcoholic beverages, and olive oil. Each component is assigned a score ranging from 0 to 2. For food groups characteristic of the Mediterranean dietary pattern (i.e. fruit, vegetables, legumes, cereals, and fish), higher consumption is assigned a higher score, whereas lower consumption of meat and processed meat and milk and dairy products received a higher score. Olive-oil use is scored according to its reported frequency of consumption. The original MEDI-LITE score ranges from 0 to 18, with higher values indicating greater adherence to the Mediterranean dietary pattern.

  35. Dietary Inflammatory Index (DII)

    Time frame: Baseline

    The Dietary Inflammatory Index (DII) is calculated from dietary intake data obtained through a 24-hour dietary recall collected through the Handydiet® software to estimate the inflammatory potential of participants' diets.

  36. Physical Activity Level (IPAQ-SF)

    Time frame: Baseline

    Physical activity is assessed using the validated International Physical Activity Questionnaire Short Form (IPAQ-SF). The seven-item questionnaire investigates the frequency and duration of walking and moderate- and vigorous-intensity physical activity performed during the previous seven days, together with time spent sitting. Weekly physical activity was expressed as metabolic equivalent of task minutes per week (MET-min/week), calculated by multiplying the MET coefficient assigned to each activity intensity by the reported duration and weekly frequency of the activity. Participants were classified as having low, moderate, or high physical activity levels according to the IPAQ scoring protocol (doi: 10.1249/01.MSS.0000078924.61453.FB.).

  37. Sleep Quality (PSQI)

    Time frame: Baseline

    Sleep quality during the previous month is assessed using the Pittsburgh Sleep Quality Index (PSQI) (doi: 10.1016/0165-1781(89)90047-4. PMID: 2748771.). The PSQI comprises 19 self-rated items grouped into seven components: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleep medication, and daytime dysfunction. Each component is scored from 0 to 3, and the seven component scores are summed to generate a global score ranging from 0 to 21. Higher scores, and in particular a cut-off of 5, indicate poorer subjective sleep quality.

  38. Quality of Life (WHOQOL-BREF)

    Time frame: Baseline

    Quality of life is assessed using the abbreviated version of the World Health Organization Quality of Life questionnaire (doi: 10.1017/s0033291798006667.). The WHOQOL-BREF comprises 26 items, including two general questions on overall quality of life and perceived health and 24 items covering four domains: physical health, psychological health, social relationships, and environment. Items are rated using five-point response scales. Domain scores are calculated according to the instrument scoring guidelines and transformed to a 4-20 or 0-100 scale, with higher scores indicating better perceived quality of life.

  39. Alcohol consumption pattern

    Time frame: Baseline

    Alcohol consumption is assessed through a structured interview investigating drinking frequency and the usual number of Alcohol Units consumed per each drinking occasion. Participants are classified as reporting no current alcohol consumption, alcohol consumption without a binge pattern, or binge-pattern alcohol consumption. Binge-pattern drinking is defined as the consumption of at least four Alcohol Units for women or at least five Alcohol Units for men on a single drinking occasion. One alcohol Unit equals to 12g of ethanol and is approximately equivalent to the quantity of alcohol in a bottle (330 ml) of beer, in a glass (125 ml) of wine, in a shot (40 ml) of spirit.

  40. Smoking status

    Time frame: Baseline

    Smoking habits are assessed through a structured interview. Participants are classified as current, former, or never smokers. Additional information collected includes the average number of cigarettes smoked per day and the duration of smoking for current and former smokers.

  41. Personal exposure to Ozone (O₃) in warm season

    Time frame: Baseline

    Personal exposure to ozone (O₃) is assessed in warm season using passive diffusion samplers worn by participants during their usual daily activities over a five consecutive day monitoring period.

    Unit of measure: µg/m3

  42. Personal Exposure to Nitrogen Dioxide (NO₂)

    Time frame: Baseline

    Personal exposure to nitrogen dioxide (NO₂) is assessed using passive diffusion samplers worn by participants during their usual daily activities over a five consecutive day monitoring period.

    Unit of measure: µg/m3

  43. Personal Exposure to Sulfur Dioxide (SO₂)

    Time frame: Baseline

    Personal exposure to sulfur dioxide (SO₂) is assessed using passive diffusion samplers worn by participants during their usual daily activities over a five consecutive day monitoring period.

    Unit of measure: µg/m3

  44. Personal Exposure to Benzene (C₆H₆)

    Time frame: Baseline

    Personal exposure to Benzene (C₆H₆) is assessed using passive diffusion samplers worn by participants during their usual daily activities over a five consecutive day monitoring period.

    Unit of measure: µg/m3

  45. Personal exposure to Toluene

    Time frame: Baseline

    Personal exposure to toluene is assessed using passive diffusion samplers worn by participants during their usual daily activities over a five consecutive day monitoring period.

    Unit of measure: µg/m3

  46. Personal exposure to Ethylbenzene

    Time frame: Baseline

    Personal exposure to ethylbenzene is assessed using passive diffusion samplers worn by participants during their usual daily activities over a five consecutive day monitoring period.

    Unit of measure: µg/m3

  47. Personal exposure to Xylenes

    Time frame: Baseline

    Personal exposure to xylenes is assessed using passive diffusion samplers worn by participants during their usual daily activities over a five consecutive day monitoring period.

    Unit of measure: µg/m3

  48. Personal exposure to Naphthalene

    Time frame: Baseline

    Personal exposure to naphthalene is assessed using passive diffusion samplers worn by participants during their usual daily activities over a five consecutive day monitoring period.

    Unit of measure: µg/m3

  49. Personal exposure to C9 Aromatic Hydrocarbons

    Time frame: Baseline

    Personal exposure to C9 aromatic hydrocarbons is assessed using passive diffusion samplers worn by participants during their usual daily activities over a five consecutive day monitoring period.

    Unit of measure: µg/m3

  50. Serum Chemokine CCL2 Concentration

    Time frame: Baseline

    Serum CCL2 concentration is measured to assess systemic inflammatory responses associated with urban air pollution exposure. CCL2 concentrations are analyzed in relation to participants' measured exposure to urban air pollutants.

    Unit of measure: pg/mL

  51. Serum Chemokine CXCL8 Concentration

    Time frame: Baseline

    Serum CXCL8 concentration is measured to assess systemic inflammatory responses associated with urban air pollution exposure. CXCL8 concentrations are analyzed in relation to participants' measured exposure to urban air pollutants.

    Unit of measure: pg/mL

  52. Serum Chemokine CXCL10 Concentration

    Time frame: Baseline

    Serum CXCL10 concentration is measured to assess systemic inflammatory responses associated with urban air pollution exposure. CXCL10 concentrations are analyzed in relation to participants' measured exposure to urban air pollutants.

    Unit of measure: pg/mL

Sponsors and collaborators

Lead sponsor

University of Pavia

Other

Collaborators

  • Istituti Clinici Scientifici Maugeri SpA

Registry information

Official study title

Impatto Dell'Ambiente Urbano Sull'età Biologica: Effetto Della qualità Dell'Aria e Dello Stress Lavorativo a Pavia su Citochine Infiammatorie e Profilo di Metilazione Del DNA

Acronym: IDEA

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Sep 14, 2026
Registry last updated
Sep 14, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.